AC Immune S.A.

ACIU · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$27,741$25,722$19,960$36,275
Short-Term Investments$80,727$101,413$125,654$129,214
Receivables$402$2,131$2,913$1,099
Inventory$0$0$0$0
Other Curr. Assets$1,582$0$0$1,104
Total Curr. Assets$113,746$131,808$152,134$171,994
Property Plant & Equip (Net)$6,861$7,416$7,947$8,088
Goodwill$0$0$0$0
Intangibles$50,416$50,416$50,416$50,416
Long-Term Investments$0$584$585$0
Tax Assets$0$0$0$0
Other NC Assets$584$0$0$415
Total NC Assets$57,861$58,416$58,948$58,919
Other Assets$0$0$0$0
Total Assets$171,607$190,224$211,082$230,913
Liabilities
Payables$1,566$2,729$2,391$2,658
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$83,725$84,676$0
Other Curr. Liab.$83,682$0$0$85,056
Total Curr. Liab.$98,286$98,969$99,246$100,838
LT Debt$0$0$0$0
Deferred Rev, NC$0$3,596$3,956$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,261$9,036$8,940$13,404
Total NC Liab.$10,877$16,512$17,038$17,805
Other Liabilities$0$0$0$0
Cap. Leases$4,661$4,919$5,175$5,427
Total Liabilities$109,163$115,481$116,284$118,643
Equity
Pref Stock$0$0$0$0
Common Stock$2,240$2,236$2,230$2,226
Retained Earnings-$419,751-$406,959-$386,212-$368,239
AOCI$3$4-$1-$5
Other Equity$0$0$0$0
Total Equity$62,444$74,743$94,798$112,270
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$171,607$190,224$211,082$230,913
Net Debt-$27,741-$25,722-$19,960-$36,275